Rodrique Mortel - Concepedia

Concepedia

Author

Rodrique Mortel

Penn State Milton S. Hershey Medical Center

Also Known As

Mortel, Rodrique, R Mortel, R. Mortel, Rodrique Mortel

20

Publications

1.4K

Citations

13

H-Index

56

Concepts

All Affiliations

Penn State Milton S. Hershey Medical Center Pennsylvania State University Duke Medical Center Wake Forest University

RM

About

Rodrique Mortel is an author at Penn State Milton S. Hershey Medical Center specializing in medicine, oncology, and obstetrics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	15	1.4K
2	Public Health	3	3	145
3	Health Sciences	2	2	68
4	Nursing	1	1	41
5	Epidemiology	1	1	114

Rodrique Mortel

×

15

Publications

1.4K

Citations

13

H-Index

	Year	Citations
Assessment of current International Federation of Gynecology and Obstetrics staging of vulvar carcinoma relative to prognostic factors for survival (A Gynecologic Oncology Group Study) Howard D. Homesley, B. Bundy, Alexander Sedlis, American Journal of Obstetrics and Gynecology Vulvar DiseasesObstetrics StagingGynecological SurgeryMedicineCurrent International Federation	1991	357
Randomized trial of cyclophosphamide plus cisplatin with or without doxorubicin in ovarian carcinoma: a Gynecologic Oncology Group Study. G A Omura, B. Bundy, Jonathan S. Berek, Journal of Clinical Oncology Randomized Clinical TrialSurgical OncologyCancer ManagementGynecologyPathology	1989	327
Preoperative evaluation of serum CA 125 levels in premenopausal and postmenopausal patients with pelvic masses. Discrimination of benign from malignant disease George D. Malkasian, Robert C. Knapp, Philip T. Lavin, American Journal of Obstetrics and Gynecology UrologyPreoperative EvaluationCervical CancerGynecological SurgerySurgical Pathology	1988	228
Oral contraceptives as risk factors for cervical adenocarcinomas and squamous cell carcinomas. J. Lacey, Louise A. Brinton, Fatima Mohamed Abbas, PubMed Contraceptive UseHormonal ContraceptiveOral ContraceptiveReproductive HealthGynecology	1999	114
Adjuvant progestogen therapy in the primary definitive treatment of endometrial cancer George C. Lewis, Nelson H. Slack, Rodrique Mortel, Gynecologic Oncology Primary Definitive TreatmentMedicineGynecologyMenstrual CycleEndometrial Cancer	1974	104
A randomized trial of hydroxyurea versus misonidazole adjunct to radiation therapy in carcinoma of the cervix Frederick B. Stehman, B. Bundy, Henry Keys, American Journal of Obstetrics and Gynecology Radiation MedicineCervical CancerRadiation TherapyMedicineGynecology	1988	66
Former Cancer Patients as Counselors of Newly Diagnosed Cancer Patients<xref ref-type="fn" rid="FN1">2</xref> Peter S. Houts, Charles W. Whitney, Rodrique Mortel, JNCI Journal of the National Cancer Institute Cancer ManagementCancer PatientsMental HealthCancer EducationFormer Cancer Patients	1986	41
A comparison of medroxyprogesterone serum concentrations by the oral or intramuscular route in patients with persistent or recurrent endometrial carcinoma Sanford Sall, Philip J. DiSaia, C. Paul Morrow, American Journal of Obstetrics and Gynecology Endocrine-related CancerMedicineIntramuscular RouteGynecologyMenstrual Cycle	1979	30
Endometrial cancer.Therapeutic decision and the staging process in “early” disease George C. Lewis, Rodrique Mortel, Nelson H. Slack Cancer Tumor PenetrationSurgical OncologyGynecological SurgeryRadiation TherapyMedicine	1977	27
Urinary polyamine levels in patients with localized malignancy Allan Lipton, Linda Sheehan, Rodrique Mortel, Cancer Polyamine LevelsUrologyTotal Polyamine LevelsGenitourinary CancerMedicine	1976	25

Page 1